Literature DB >> 2886648

Taxol is converted to 7-epitaxol, a biologically active isomer, in cell culture medium.

I Ringel, S B Horwitz.   

Abstract

The hydrolysis products of taxol have been isolated by high-performance liquid chromatography and identified by nuclear magnetic resonance and mass spectroscopy. In contrast to taxol, the major hydrolysis product, baccatin III, has little cytotoxic activity and does not promote in vitro microtubule assembly. In cell culture medium, the concentration of taxol decreases with time and 7-epitaxol, which exhibits properties comparable to those of taxol both on cells and on in vitro microtubuli polymerization, is formed. Baccatin III is found in small quantities in the cell medium, although it is barely detectable within the cells. It is concluded that 7-epitaxol is the major derivative of taxol found in cells and that its presence does not alter, in a major way, the overall biological activity of taxol.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886648

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  Cell cycle checkpoint models for cellular pharmacology of paclitaxel and platinum drugs.

Authors:  Ardith W El-Kareh; Rachel E Labes; Timothy W Secomb
Journal:  AAPS J       Date:  2008-02-05       Impact factor: 4.009

2.  D+: software for high-resolution hierarchical modeling of solution X-ray scattering from complex structures.

Authors:  Avi Ginsburg; Tal Ben-Nun; Roi Asor; Asaf Shemesh; Lea Fink; Roee Tekoah; Yehonatan Levartovsky; Daniel Khaykelson; Raviv Dharan; Amos Fellig; Uri Raviv
Journal:  J Appl Crystallogr       Date:  2019-02-01       Impact factor: 3.304

3.  Development and characterization of biodegradable chitosan films for local delivery of Paclitaxel.

Authors:  Anand Babu Dhanikula; Ramesh Panchagnula
Journal:  AAPS J       Date:  2004-10-11       Impact factor: 4.009

4.  Mdr1 transfection causes enhanced apoptosis by paclitaxel: an effect independent of drug efflux function of P-glycoprotein.

Authors:  D Li; J L Au
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

5.  Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right?

Authors:  Sara A Abouelmagd; Bo Sun; Alice C Chang; Youn Jin Ku; Yoon Yeo
Journal:  Mol Pharm       Date:  2015-02-17       Impact factor: 4.939

6.  Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors.

Authors:  Gaurav Bajaj; Mi Ran Kim; Sulma I Mohammed; Yoon Yeo
Journal:  J Control Release       Date:  2011-12-09       Impact factor: 9.776

7.  Experimental and computational assessment of the synergistic pharmacodynamic drug-drug interactions of a triple combination therapy in refractory HER2-positive breast cancer cells.

Authors:  Tanaya R Vaidya; Sihem Ait-Oudhia
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-11-13       Impact factor: 2.745

8.  Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer.

Authors:  Michio Kosugi; Akira Miyajima; Eiji Kikuchi; Takeo Kosaka; Yutaka Horiguchi; Masaru Murai
Journal:  Hum Cell       Date:  2007-02       Impact factor: 4.174

9.  Cytotoxicity of taxol in vitro against human and rat malignant brain tumors.

Authors:  M A Cahan; K A Walter; O M Colvin; H Brem
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  Taxol and taxotere in bladder cancer: in vitro activity and urine stability.

Authors:  C Rangel; H Niell; A Miller; C Cox
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.